ELDN: Eledon Pharmaceuticals, Inc. Stock

by  •  • Comments Off on ELDN: Eledon Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 215.06
Enterprise Value ($M) 208.31
Book Value ($M) 76.06
Book Value / Share 1.27
Price / Book 2.83
NCAV ($M) 42.99
NCAV / Share 0.72
Price / NCAV 5.00

Profitability (mra)
Return on Invested Capital (ROIC) -0.28
Return on Assets (ROA) -0.24
Return on Equity (ROE) -0.26

Liquidity (mrq)
Quick Ratio 6.53
Current Ratio 6.53

Balance Sheet (mrq) ($M)
Current Assets 81.51
Assets 114.58
Liabilities 38.52
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Frazier Life Sciences Public Fund, L.P. 2.00 -66.96
02-14 13G/A Armistice Capital, Llc 4.99 32.72
11-05 13G Ra Capital Management, L.p. 6.10
10-31 13G/A Biotechnology Value Fund L P 10.50 45.45
2024-02-14 13G/A Cormorant Asset Management, LP 0.00 -100.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-19 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-19 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A (Amendment No. 1)
2024-08-19 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A (Amendment No. 2)
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-04-26 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A (Amendment No. 1)
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-14 17,861 108,792 16.42
2025-03-13 31,381 170,994 18.35
2025-03-12 25,606 252,801 10.13
2025-03-11 41,422 201,435 20.56
2025-03-10 91,651 377,811 24.26

(click for more detail)

Similar Companies
DWTX – Dogwood Therapeutics, Inc. DYAI – Dyadic International, Inc.
EDSA – Edesa Biotech, Inc. ELTX – Elicio Therapeutics, Inc.
ELUT – Elutia Inc.


Financial data and stock pages provided by
Fintel.io